Vascular Pharmaceuticals, Inc. Report issue

For profit Phase 2
Founded: Research Triangle Park NC United States (2005)
Status: Acquired by Johnson and Johnson (2017)

Organization Overview

First Clinical Trial
2014
NCT02251067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

vpi-2690b (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Nephropathies (Phase 2)

Kidney Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1